RTTNews | Jan 25, 2021 08:54AM EST

08:54 Monday, January 25, 2021 (RTTNews) - DURECT Says First Patient Dosed In Phase 2b AHFIRM Study Of DUR-928 In Severe Alcohol-Associated Hepatitis

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved